The Patented Medicine Prices Review Board reviewed classified no NAS as a substantial improvement in 2021. This statistic depicts the new active substances (NASs) reviewed by the Patented Medicine Prices Review Board in Canada from 2014 to 2021, by therapeutic improvement.
Number of new active substances (NASs) reviewed by PMPRB Canada from 2014 to 2021, by therapeutic improvement
The year of reporting reflects the year in which the Notice of Compliance was issued rather than the year that the PMPRB conducted its price review.
Medicines reviewed by the PMPRB prior to the implementation of the 2010 Guidelines have been merged as follows:
category 2 medicines are included in the Breakthrough category; category 1 medicines are included in the Slight/No
Improvement category; and category 3 medicines are included in the Moderate Improvement category.
* New active substances not reported to the PMPRB as of each Annual Report.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PMPRB. (December 12, 2023). Number of new active substances (NASs) reviewed by PMPRB Canada from 2014 to 2021, by therapeutic improvement [Graph]. In Statista. Retrieved September 20, 2024, from https://www.statista.com/statistics/711846/new-nass-reviewed-by-medicine-prices-review-board-in-canada-by-improvement/
PMPRB. "Number of new active substances (NASs) reviewed by PMPRB Canada from 2014 to 2021, by therapeutic improvement." Chart. December 12, 2023. Statista. Accessed September 20, 2024. https://www.statista.com/statistics/711846/new-nass-reviewed-by-medicine-prices-review-board-in-canada-by-improvement/
PMPRB. (2023). Number of new active substances (NASs) reviewed by PMPRB Canada from 2014 to 2021, by therapeutic improvement. Statista. Statista Inc.. Accessed: September 20, 2024. https://www.statista.com/statistics/711846/new-nass-reviewed-by-medicine-prices-review-board-in-canada-by-improvement/
PMPRB. "Number of New Active Substances (Nass) Reviewed by Pmprb Canada from 2014 to 2021, by Therapeutic Improvement." Statista, Statista Inc., 12 Dec 2023, https://www.statista.com/statistics/711846/new-nass-reviewed-by-medicine-prices-review-board-in-canada-by-improvement/
PMPRB, Number of new active substances (NASs) reviewed by PMPRB Canada from 2014 to 2021, by therapeutic improvement Statista, https://www.statista.com/statistics/711846/new-nass-reviewed-by-medicine-prices-review-board-in-canada-by-improvement/ (last visited September 20, 2024)
Number of new active substances (NASs) reviewed by PMPRB Canada from 2014 to 2021, by therapeutic improvement [Graph], PMPRB, December 12, 2023. [Online]. Available: https://www.statista.com/statistics/711846/new-nass-reviewed-by-medicine-prices-review-board-in-canada-by-improvement/
